Minimizing Diabetes-related Complications and Increasing Glycemic Control: Appropriate Glycemic Screening and Assessment and the Selection of Non-insulin Therapies Based on Safety, Efficacy, and Pathophysiological Targets
Despite the availability of up-to-date guidelines and a plethora of available antidiabetic medications, a large proportion of patients with type 2 diabetes mellitus (T2DM) lack adequate glycemic control. The current practice of screening and assessment of glycemia and associated comorbidities and the lack of understanding of T2DM pathophysiology and the pathophysiological targets of non-insulin therapies are some of the factors that lead to suboptimal care resulting in higher risk of associated macrovascular and microvascular complications. Thus, in this educational activity, the expert faculty will discuss appropriate screening and assessment for glycemia and associated comorbidities as well as review the safety, efficacy, mechanisms of action and place for non-insulin therapies within the treatment algorithm.
After completing this activity, the participant should be better able to:
- Minimize complications by routinely screening and assessing glycemia and associated comorbidities in patients with type 2 diabetes
- Collaborate with other health professionals to improve adherence of patients with T2DM to pharmacological and non-pharmacological interventions
- Incorporate novel non-insulin therapies appropriately in patients with T2DM based on their mechanism of action and their pathophysiological target to improve outcomes
- Summarize the current understanding of the pathophysiology of type 2 diabetes
If you are using a mobile device, this activity may not view properly.
Published August 12, 2014